These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system. Houp JA, Schillinger KP, Eckstein AJ, Vega RM, Desai NM, Lonze BE, Jackson AM. Hum Immunol; 2017 Jan; 78(1):49-53. PubMed ID: 27890719 [Abstract] [Full Text] [Related]
3. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients. Baxter-Lowe LA, Kucheryavaya A, Tyan D, Reinsmoen N. Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168 [Abstract] [Full Text] [Related]
4. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies. Gebel HM, Kasiske BL, Gustafson SK, Pyke J, Shteyn E, Israni AK, Bray RA, Snyder JJ, Friedewald JJ, Segev DL. Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):505-11. PubMed ID: 26839235 [Abstract] [Full Text] [Related]
5. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist. Hickey MJ, Zheng Y, Valenzuela N, Zhang Q, Krystal C, Lum E, Tsai EW, Lipshutz GS, Gritsch HA, Danovitch G, Veale J, Gjertson D, Cecka M, Reed EF. Hum Immunol; 2017 Jan 07; 78(1):41-48. PubMed ID: 27818166 [Abstract] [Full Text] [Related]
7. Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States. Parsons RF, Locke JE, Redfield RR, Roll GR, Levine MH. Hum Immunol; 2017 Jan 07; 78(1):30-36. PubMed ID: 27773831 [Abstract] [Full Text] [Related]
10. Stem cell donor HLA typing improves CPRA in kidney allocation. Kransdorf EP, Pando MJ, Stewart D, Lindblad K, Bray R, Murphey C, Kaur N, Patel JK, Kim I, Zhang X, Maiers M, Kobashigawa JA, Gragert L. Am J Transplant; 2021 Jan 07; 21(1):138-147. PubMed ID: 32558252 [Abstract] [Full Text] [Related]
11. Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System. Sethi S, Najjar R, Peng A, Mirocha J, Vo A, Bunnapradist S, Jordan SC, Huang E. Am J Kidney Dis; 2019 May 07; 73(5):605-614. PubMed ID: 30929853 [Abstract] [Full Text] [Related]
13. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan. Shen SW, Chang CK, Gao YS, Hsu PJ, Cheng SC, Liu FY, Lo SC. J Formos Med Assoc; 2017 Dec 07; 116(12):956-963. PubMed ID: 29037453 [Abstract] [Full Text] [Related]
14. The new KAS: Challenges and opportunities. Gebel HM, Kamoun M. Hum Immunol; 2017 Jan 07; 78(1):54-56. PubMed ID: 27845172 [No Abstract] [Full Text] [Related]
16. HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S. Kamoun M, Phelan D, Noreen H, Marcus N, Klingman L, Gebel HM. Hum Immunol; 2017 Jan 07; 78(1):19-23. PubMed ID: 27840088 [Abstract] [Full Text] [Related]